December 15, 2010 -- Xiangxue Pharmaceutical, a TCM drug company based in Guangzhou, completed its IPO on the ChiNext exchange today, raising 373 million RMB. The company issued 31 million shares at 33.99 RMB per share, a price-earnings ratio of 83. The company’s stock rose an additional 18% to 40.13 in post-IPO trading. More details...
